CancerAYAConnectNCT06171945
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
A study testing AYA Connect intervention, Positive Psychology (PP) intervention and Positive Psychology Plus (PP+) intervention in people with Cancer and Physical Activity, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.
Trial summary
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of theory-based mobile weight loss interventions for survivors of adolescent and young adult cancer (AYAs). Read more about this study
- Who is it for?
- Ages 18 to 39 years
- Conditions the study is for
- Cancer, Physical Activity, Cancer Survivorship
- What is being tested?
- AYA Connect intervention, Positive Psychology (PP) intervention and Positive Psychology Plus (PP+) intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 63 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Mar 2024to 5 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 39 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Currently age 18-39
- Diagnosed with first invasive cancer between the ages of 15-39 years old
- Within 10 years of diagnosis with no evidence of progressive disease or second primary cancers
- Completed active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy, and/or definitive surgical intervention) at least six months prior to enrollment, except maybe receiving "maintenance" therapy to prevent recurrences
- Body Mass Index (BMI) of 25-50 kg/m2
Who cannot join
- Type 1 diabetes or currently receiving medical treatment for Type 2 diabetes
- Report a history of heart attack or stroke within the previous 6 months
- Health problems that preclude the ability to walk for physical activity
- Lost 5% or more of body weight (and kept it off) in the last 3 months
- Past diagnosis of or receiving treatment for a clinically diagnosed eating disorder (anorexia nervosa or bulimia nervosa) or any compensatory behaviors within the previous 3 months
- Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months
Show all 16Show fewer
- Untreated thyroid disease or any changes (type or dose) in thyroid medication in the last 6 months
- Hospitalization for depression or other psychiatric disorder within the past 12 months
- History of psychotic disorder or bipolar disorder
- Currently participating in a weight loss, nutrition, or physical activity study or program or other study that would interfere with this study
- Currently using prescription medications with known effects on appetite or weight.
- Previous surgical procedure for weight loss or planned weight loss surgery in the next 6 months
- Inability to speak and read English
- Do not have an iPhone with active data and text messaging plan
- No Internet access
- Not willing to be randomized to either intervention arm
Trial locations and contacts
1 site in 1 country.
United States1 site
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27599
About this study
Official title: A Pilot Randomized Trial of a Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of theory-based mobile weight loss interventions for survivors of adolescent and young adult cancer (AYAs). The interventions use a mobile smartphone application, previously developed for individuals at risk for type 2 diabetes and adapted for AYAs, that integrates weight and physical activity from digital devices with simplified dietary monitoring in a behavioral weight loss program.
Read the detailed description
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of three adapted theory-based, mobile weight loss interventions delivered via a native smartphone application among AYAs: 1) AYA Connect; 2) AYA Connect enhanced with positive psychology strategies (AYA Connect-PP); and 3) AYA Connect enhanced with positive psychology strategies plus coaching (AYA Connect-PP+).
The 3-month interventions are aimed at promoting improvements in diet quality consistent with recommendations for cancer survivors, a decrease in energy intake, an increase in energy expenditure, modest weight loss, and an increase in positive affect. The 3-month interventions will be followed by a 3-month maintenance phase (no contact). Assessments will occur at baseline, 3 (post-intervention), and 6 months (maintenance). Weight will be collected via smart scales mailed to participants. Adherence measures will include daily self-monitoring of weight (smart scale), physical activity (activity tracker), and dietary intake (food log in AYA Connect app).
Young adults (n=60), ages 18-39, diagnosed with invasive malignancy between the ages of 15-39 years, post-cancer treatment, with body mass index (BMI) of 25-50 kg/m2 will be recruited from around the United States to participate in the pilot randomized trial. Participants will be randomized into one of three conditions: 1) AYA Connect intervention; 2) AYA Connect-PP intervention; and 3) AYA Connect-PP+ intervention.
Group 1: AYA Connect Intervention: These participants will receive a smart scale, activity tracker, an individual kickoff video chat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Group 2: AYA Connect-PP Intervention: In addition to the intervention components Group 1 will receive, these participants will also receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
Group 3: AYA Connect-PP+ Intervention: In addition to the intervention components Group 2 will receive, these participants also will receive weekly individual video chat sessions with a health coach.
- Conditions
- Cancer, Physical Activity, Cancer Survivorship, Mental Health, Obesity
- Being tested
- AYA Connect intervention, Positive Psychology (PP) intervention, Positive Psychology Plus (PP+) intervention
- Keywords
- adolescent, young adult, mobile application, physical activity, nutrition, overweight, positive psychology, digital intervention, diet, weight loss, weight management, bladder cancer, bone cancer, brain cancer, breast cancer, cervical cancer, colon cancer, endometrial cancer, head and neck cancer, leukemia
- Medical subject headings
- Neoplasms, Motor Activity, Psychological Well-Being, Obesity, Overweight, Weight Loss, Urinary Bladder Neoplasms, Bone Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AYA Connect interventionBehavioural
Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Positive Psychology (PP) interventionBehavioural
Participants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
Positive Psychology Plus (PP+) interventionBehavioural
Participants will receive weekly individual videochat sessions with a health coach.
| Study group | Role | What they receive |
|---|---|---|
| AYA Connect | Experimental | Adolescent and young adult cancer survivors receive AYA Connect intervention. Receives: Behavioral: AYA Connect intervention |
| AYA Connect-PP | Experimental | Adolescent and young adult cancer survivors receive AYA Connect-PP intervention. Receives: Behavioral: AYA Connect intervention; Behavioral: Positive Psychology (PP) intervention |
| AYA Connect-PP+ | Experimental | Adolescent and young adult cancer survivors receive AYA Connect-PP+ intervention. Receives: Behavioral: AYA Connect intervention; Behavioral: Positive Psychology (PP) intervention; Behavioral: Positive Psychology Plus (PP+) intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of interventions as measured by accrual rate
Feasibility of interventions as measured by accrual rate will be calculated as the number of adolescent and young adult cancer (AYA) survivors who agreed to participate divided by the number of months of recruitment
Measured: at 3 months
Feasibility of interventions as measured by participation rate
Feasibility of interventions as measured by participation rate will be calculated as the number of participants who agreed to participate divided by the number of eligible AYA survivors.
Measured: at 3 months
Feasibility of interventions as measured by retention rate
Feasibility of interventions as measured by retention rate will be calculated as the number of AYA survivor participants who completed 3-month measures divided by the number who participated.
Measured: At 3 months
Secondary outcomes (20)
Retention rate at 6 months
Retention rate at 6 months, calculated by the number of participants who completed all study measures at the 6-month time point divided by the number who participated.
Measured: At 6 months
Acceptability of Young Adult Cancers (AYAs) Connect
Acceptability of the interventions will be measured by ratings of program acceptability and satisfaction. Participants will provide ratings on the helpfulness and difficulty of the program's behavioral goals (e.g., diet and physical activity goals) using an 8-point scale (1 = Not satisfied/Very difficult to 8 = Very satisfied/very easy). Additional questions will ask participants about the helpfulness of intervention features (e.g., lessons, feedback messages) for reaching their weight goals (1 = Not at all helpful to 4 = Extremely helpful). Higher scores indicate greater acceptability.
Measured: At 3 and 6 month
Adherence to dietary tracking
Number of days red foods (high-calorie, high-fat foods) are tracked, as measured by the food log data in the AYA Connect app. Participants will be asked to log their red foods in the app daily.
Measured: Up to 6 month
Adherence to physical activity monitoring
Number of days physical activity is tracked, as measured by activity tracker
Measured: Up to 6 month
Adherence to self-weighing
Number of days weighed, as measured by smart scale
Measured: Up to 6 month
Change in weight
Change in weight, as measured by smart scale, from baseline to 3 and 6 months.
Measured: Up to 6 month
Change in energy intake
Change in energy intake (kcal), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24). The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate energy intake.
Measured: from the baseline to 3 and 6 month
Change in saturated fat intake
Change in saturated fat intake (% kcal), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24 The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate saturated fat intake.
Measured: from the baseline to 3 and 6 month
Change in fruit and vegetable consumption
Change in fruit and vegetable consumption (cups), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24). The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate average fruit and vegetable consumption.
Measured: from the baseline to 3 and 6 month
Change in fiber consumption
Change in fiber consumption (g), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24). The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate fiber consumption.
Measured: from the baseline to 3 and 6 month
Change in Healthy Eating Index score
Change in Healthy Eating Index (HEI) score, measured using the HEI and the NCI Automated Self-Administered 24-hour Recall (ASA-24). The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate HEI. HEI scores range from 0 to 100, with higher scores indicating greater adherence to the Dietary Guidelines for Americans.
Measured: from the baseline to 3 and 6 month
Change in weekly minutes of moderate-to-vigorous activity
Changes in weekly minutes of moderate-to-vigorous activity, computed from the participant's activity tracker data and averaged over a minimum of 4 out of a 7-day period. Participants will be instructed to wear the activity tracker at all times.
Measured: From baseline to 3 and 6 months
Change in steps per day
Changes in daily steps, were computed from the participant's activity tracker data and averaged over a minimum of 4 out of a 7-day period. Participants will be instructed to wear the activity tracker at all times.
Measured: From baseline to 3 and 6 months
Change in self-reported physical activity
Change in self-reported physical activity, measured using the Paffenbarger Activity Scale (PAQ). The PAQ provides an estimate of minutes per week of moderate-to-vigorous intensity, and calories/week of light (5 kcal/min), medium (7.5 kcal/min), and high (10 kcal/min) intensity activities. PAQ changes have been predictive of weight change.
Measured: From baseline to 3 and 6 months
Change in frailty index
Change in frailty index, measured using the FRAIL Questionnaire. The FRAIL Questionnaire assesses: 1) self-reported fatigue (1 item from Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health), 2) weight loss, 3) comorbidities (11 items from UNC Health Registry Comorbidity Assessment), 4) difficulty with ambulation (1 item from PROMIS Global Health), and 5) ability to overcome resistance (1 item from Medical Outcomes Study 36-Item Short Form). Positive responses for these components are summed to create the FRAIL index (range 0-5). A value > 3 is considered frail, and a value of 2 is considered prefrail.
Measured: From baseline to 3 and 6 months
Change in health-related quality of life
Change in health-related quality of life, measured using the Medical Outcomes Study 36-Item Short Form (SF-36) survey. This survey includes 36 items with eight subscales (physical functioning, role limitations due to physical problems, social functioning, bodily pain, general mental health, role limitations due to emotional problems, vitality, and general health perceptions). Responses are coded on a scale of 0 to 100, where 0 is the worst possible health and 100 is the most favorable health score. The coded responses will be summed to yield a Physical Component Summary (PCS) score and a Mental Component Summary (MCS) score.
Measured: From baseline to 3 and 6 months
Change in depressive symptoms
Change in depressive symptoms, measured by the Center for Epidemiological Studies Depression Scale (CES-D). The CES-D is a self-report depression scale including 20 items that relate to depressive feelings and behaviors during the past week. Response options range from 0 (rarely or none of the time) to 3 (most or almost All the Time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.
Measured: From baseline to 3 and 6 months
Change in anxiety symptoms
Change in anxiety symptoms, as measured using the Generalized Anxiety Disorder 7-item scale (GAD-7). Possible scores range from 0 to 21, with higher scores reflecting greater symptom severity; cut-points of 5, 10, and 15 correspond to mild, moderate, and severe levels of anxiety.
Measured: From baseline to 3 and 6 months
Change in perceived stress
Change in perceived stress, measured by the 10-item Perceived Stress Scale (PSS-10). PSS-10 measures overall perceived stress during the past month. Factor analysis supports a two-factor correlated model with perceived self-efficacy and perceived helplessness subscales.
Measured: From baseline to 3 and 6 months
Change in positive and negative affect
Change in positive and negative affect, measured using the Positive and Negative Affect Schedule (PANAS). PANAS is a 20-item scale divided into two subscales to measure positive and negative affect. Each item is rated on a five-point Likert scale from 1 (very slightly or not at all) to 5 (extremely) and are summed to yield scores for each subscale.
Measured: From baseline to 3 and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2023
- Study start1 Mar 2024
- Primary completion13 Jul 2025
- Study completion5 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by UNC Lineberger Comprehensive Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 63 participants (actual)
Sponsor and investigators
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Carmina Valle, PhD, Principal investigator, UNC Lineberger Comprehensive Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06171945
- Sponsor's protocol ID
- LCCC2133
- Acronym
- AYAConnect
- Status last verified
- Oct 2025
- First submitted
- 27 Nov 2023
- Last updated
- 27 Oct 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pilot Randomized Trial of a Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
- ClinicalTrials.gov ID
- NCT06171945
- Acronym / sponsor ID
- AYAConnect / LCCC2133
- Conditions
- Cancer, Physical Activity, Cancer Survivorship, Mental Health, Obesity
- Keywords
- adolescent, young adult, mobile application, physical activity, nutrition, overweight, positive psychology, digital intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 63 participants (actual)
- Lead sponsor
- UNC Lineberger Comprehensive Cancer CenterUniversity, hospital or other
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- 13 Jul 2025 (actual)
- Study completion
- 5 Oct 2025 (actual)
- First posted
- 15 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of theory-based mobile weight loss interventions for survivors of adolescent and young adult cancer (AYAs). The interventions use a mobile smartphone application, previously developed for individuals at risk for type 2 diabetes and adapted for AYAs, that integrates weight and physical activity from digital devices with simplified dietary monitoring in a behavioral weight loss program.
Detailed description
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of three adapted theory-based, mobile weight loss interventions delivered via a native smartphone application among AYAs: 1) AYA Connect; 2) AYA Connect enhanced with positive psychology strategies (AYA Connect-PP); and 3) AYA Connect enhanced with positive psychology strategies plus coaching (AYA Connect-PP+).
The 3-month interventions are aimed at promoting improvements in diet quality consistent with recommendations for cancer survivors, a decrease in energy intake, an increase in energy expenditure, modest weight loss, and an increase in positive affect. The 3-month interventions will be followed by a 3-month maintenance phase (no contact). Assessments will occur at baseline, 3 (post-intervention), and 6 months (maintenance). Weight will be collected via smart scales mailed to participants. Adherence measures will include daily self-monitoring of weight (smart scale), physical activity (activity tracker), and dietary intake (food log in AYA Connect app).
Young adults (n=60), ages 18-39, diagnosed with invasive malignancy between the ages of 15-39 years, post-cancer treatment, with body mass index (BMI) of 25-50 kg/m2 will be recruited from around the United States to participate in the pilot randomized trial. Participants will be randomized into one of three conditions: 1) AYA Connect intervention; 2) AYA Connect-PP intervention; and 3) AYA Connect-PP+ intervention.
Group 1: AYA Connect Intervention: These participants will receive a smart scale, activity tracker, an individual kickoff video chat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Group 2: AYA Connect-PP Intervention: In addition to the intervention components Group 1 will receive, these participants will also receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
Group 3: AYA Connect-PP+ Intervention: In addition to the intervention components Group 2 will receive, these participants also will receive weekly individual video chat sessions with a health coach.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| AYA Connect | Experimental | Behavioral: AYA Connect interventionAdolescent and young adult cancer survivors receive AYA Connect intervention. |
| AYA Connect-PP | Experimental | Behavioral: AYA Connect intervention, Behavioral: Positive Psychology (PP) interventionAdolescent and young adult cancer survivors receive AYA Connect-PP intervention. |
| AYA Connect-PP+ | Experimental | Behavioral: AYA Connect intervention, Behavioral: Positive Psychology (PP) intervention, Behavioral: Positive Psychology Plus (PP+) interventionAdolescent and young adult cancer survivors receive AYA Connect-PP+ intervention. |
Who may qualify
- Ages
- 18 to 39 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Currently age 18-39
- Diagnosed with first invasive cancer between the ages of 15-39 years old
- Within 10 years of diagnosis with no evidence of progressive disease or second primary cancers
- Completed active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy, and/or definitive surgical intervention) at least six months prior to enrollment, except maybe receiving "maintenance" therapy to prevent recurrences
- Body Mass Index (BMI) of 25-50 kg/m2
Key exclusion criteria (16 listed)
- Type 1 diabetes or currently receiving medical treatment for Type 2 diabetes
- Report a history of heart attack or stroke within the previous 6 months
- Health problems that preclude the ability to walk for physical activity
- Lost 5% or more of body weight (and kept it off) in the last 3 months
- Past diagnosis of or receiving treatment for a clinically diagnosed eating disorder (anorexia nervosa or bulimia nervosa) or any compensatory behaviors within the previous 3 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AYA Connect interventionParticipants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages. | Behavioural | AYA Connect, AYA Connect-PP, AYA Connect-PP+ |
| Positive Psychology (PP) interventionParticipants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises. | Behavioural | AYA Connect-PP, AYA Connect-PP+ |
| Positive Psychology Plus (PP+) interventionParticipants will receive weekly individual videochat sessions with a health coach. | Behavioural | AYA Connect-PP+ |
Primary outcome
Feasibility of interventions as measured by accrual rate
Time frame: at 3 months
Feasibility of interventions as measured by accrual rate will be calculated as the number of adolescent and young adult cancer (AYA) survivors who agreed to participate divided by the number of months of recruitment
Feasibility of interventions as measured by participation rate
Time frame: at 3 months
Feasibility of interventions as measured by participation rate will be calculated as the number of participants who agreed to participate divided by the number of eligible AYA survivors.
Feasibility of interventions as measured by retention rate
Time frame: At 3 months
Feasibility of interventions as measured by retention rate will be calculated as the number of AYA survivor participants who completed 3-month measures divided by the number who participated.
20 secondary outcomes
Retention rate at 6 months
Time frame: At 6 months
Acceptability of Young Adult Cancers (AYAs) Connect
Time frame: At 3 and 6 month
Adherence to dietary tracking
Time frame: Up to 6 month
Adherence to physical activity monitoring
Time frame: Up to 6 month
Adherence to self-weighing
Time frame: Up to 6 month
Change in weight
Time frame: Up to 6 month
Change in energy intake
Time frame: from the baseline to 3 and 6 month
Change in saturated fat intake
Time frame: from the baseline to 3 and 6 month
Change in fruit and vegetable consumption
Time frame: from the baseline to 3 and 6 month
Change in fiber consumption
Time frame: from the baseline to 3 and 6 month
Change in Healthy Eating Index score
Time frame: from the baseline to 3 and 6 month
Change in weekly minutes of moderate-to-vigorous activity
Time frame: From baseline to 3 and 6 months
Change in steps per day
Time frame: From baseline to 3 and 6 months
Change in self-reported physical activity
Time frame: From baseline to 3 and 6 months
Change in frailty index
Time frame: From baseline to 3 and 6 months
Change in health-related quality of life
Time frame: From baseline to 3 and 6 months
Change in depressive symptoms
Time frame: From baseline to 3 and 6 months
Change in anxiety symptoms
Time frame: From baseline to 3 and 6 months
Change in perceived stress
Time frame: From baseline to 3 and 6 months
Change in positive and negative affect
Time frame: From baseline to 3 and 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2025.
- Clinical trials at UNC LinebergerLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carmina Valle, PhD principal investigator
UNC Lineberger Comprehensive Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AYA Connect intervention, Positive Psychology (PP) intervention and Positive Psychology Plus (PP+) intervention in people with Cancer and Physical Activity, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of interventions as measured by accrual rate (time frame: at 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2025.